GLP1R and myocardial infarction: In a meta-nalysis including 800 patients with myocardial infarction undergoing angioplasty, GLP-1 RA vs. placebo treatment increased LVEF by 2.5% and reduced the infarct size by 5.3 g (95% CI: −10.4 to −0.2) [170].